Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CeloNova logo — A global leader in medical devices, offering innovative Inte...

CeloNova

A global leader in medical devices, offering innovative Interventional Cardiology and Endovascular solutions across over fifty countries.

Founded 2000 51-200 employees Venture round Total: $20.84M Biotechnology, Manufacturing +1

General Information

Company Name CeloNova
Founded Year 2000
Founders / Decision Makers
Team member
Employees 51-200
Industries Biotechnology, Manufacturing, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CeloNova. To contact CeloNova, visit celonova.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CeloNova compare?

A PDF of CeloNova and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CeloNova soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CeloNova

CeloNova BioSciences, Inc. is a standout player in the medical devices industry, offering innovative Interventional Cardiology and Endovascular solutions across over fifty countries. The company, established in 2000, is centered in San Antonio, Texas. With a strong focus on the development, manufacturing, and marketing of Interventional Cardiology and Endovascular products, CeloNova has made a notable impact in the biotechnology, manufacturing, and medical devices sectors. Notably, the company's regional offices are strategically located in Germany, France, the United Kingdom, the Netherlands, and Austria, and it operates production facilities in California, U.S.A., and Germany. The latest feather in its cap is the Venture Round investment at 30 November 2018, with the backing of WP Global Partners. This investment serves as a testament to the company's potential and underscores its trajectory as a noteworthy player in the global medical devices arena. CeloNova's impressive reach and continual commitment to innovation position it as a company to watch in the coming years.

Business keywords: Interventional Cardiology, Endovascular Solutions, Global Presence, Innovative Technology, International Operations, Cardiovascular Disease, NanoCoated Stent, Innovation, Global Expansion, Market Penetration

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
WP Global Partners
WP Global Partners
30 Nov 2018
Venture Round $20.84M -
15 Feb 2011
Venture Round Undisclosed 2
FCA Venture Partners Clayton Associates
FCA Venture Partners, Clayton Associates
01 Mar 2003

CeloNova Alternatives & Competitors

CeloNova vs
Relisys
Relisys

Pioneering advanced cardiovascular medical devices for life-saving heart treatments.

Private Equity
201-500 employees
Health Care, Manufacturing
CeloNova vs
Tryton
Tryton United States

Pioneering stent solutions for advanced cardiovascular care across multiple countries since 2003.

Venture round
29 employees
Health Care, Manufacturing
Compare CeloNova vs Tryton
CeloNova vs
Relisys Medical Devices Limited
Relisys Medical Devices Limited India

relisysmedicaldevices

208 employees
Industrial, Manufacturing
Also compare with: CeloNova vs Translumina Translumina

FAQ About CeloNova

A global leader in medical devices, offering innovative Interventional Cardiology and Endovascular solutions across over fifty countries.
CeloNova was founded in 2000.
CeloNova operates in Biotechnology, Manufacturing and Medical Devices. Its work centres on Interventional Cardiology, Endovascular Solutions, Global Presence and Innovative Technology.
CeloNova has approximately 51-200 employees.
CeloNova has completed 3 funding rounds, raising a total of $20.84M. The latest funding stage is Venture round.
Top alternatives and competitors to CeloNova include Relisys, Tryton, Relisys Medical Devices Limited, Translumina, Sahajanand Medical Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CeloNova and Relisys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CeloNova, https://bouncewatch.com/company/celonova, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes